fwp
Free Writing Prospectus
Filed pursuant to Rule 433
Dated December 8, 2010
Relating to
Preliminary Prospectus Supplement dated December 8, 2010 to
Prospectus dated May 13, 2008
Registration Statement No. 333-150884
Final Term Sheet
(Healthcare Realty Logo)
$400,000,000 5.750% Notes due 2021
     
Issuer:
  Healthcare Realty Trust Incorporated
 
   
Principal Amount:
  $400,000,000
 
   
Title of Securities:
  5.750% Notes due 2021
 
   
Trade Date:
  December 8, 2010
 
   
Original Issue Date (Settlement Date):
  December 13, 2010
 
   
Maturity Date:
  January 15, 2021
 
   
Benchmark Treasury:
  2.625% due November 15, 2020
 
   
Benchmark Treasury Yield:
  3.230%
 
   
Spread to Benchmark Treasury:
  T+ 262.5 basis points
 
   
Coupon:
  5.750% per annum
 
   
Yield to Maturity:
  5.855%
 
   
Public Offering Price:
  99.200%
 
   
Interest Payment Dates:
  Semi-annually in arrears on each January 15 and July 15, commencing July 15, 2011.
 
   
Make-Whole Call:
  T+ 40 basis points
 
   
CUSIP/ISIN:
  421946 AG9/US421946AG98
 
   
Ratings:
  Baa3 by Moody’s Investors Service (positive outlook), BBB- by Standard and Poor’s Ratings Services (stable outlook) and BBB by Fitch Ratings (negative outlook)
 
   
Book-Running Managers:
  Barclays Capital Inc.
UBS Securities LLC
Credit Agricole Securities (USA) Inc.
J.P. Morgan Securities Inc.
Merrill Lynch, Pierce, Fenner & Smith Incorporated
Morgan Keegan & Company, Inc.
Wells Fargo Securities, LLC
 
   
Co-Managers:
  Fifth Third Securities, Inc.
SunTrust Robinson Humphrey, Inc.
BMO Capital Markets Corp.
Scotia Capital (USA) Inc.
Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
The issuer has filed a registration statement (including a prospectus) and a preliminary prospectus supplement dated December 8, 2010 with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the related preliminary prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Barclays Capital Inc. toll-free at 888-603-5847 or UBS Securities LLC toll-free at 877-827-6444, ext. 561 3884.
Any disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded. Such disclaimers or other notices were automatically generated as a result of this communication being sent via Bloomberg or another email system.